What starts as breathlessness can turn fatal within minutes, doctors warn that quick action, correct inhaler use and timely ...

In a shocking medical case, a California woman injected herself with black widow spider venom in a misguided attempt to get ...

The FDA approved depemokimab (Exdensur) as the first ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype, GSK announced.

The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an eosinophilic phenotype, according to a press release from GSK.Depemokimab ...

Metro Manila hospitals are bracing for the expected influx of injuries and other emergency cases due to firecrackers as the ...

Australians are starting the New Year with cheaper medicines, after major changes to the Pharmaceutical Benefits Scheme came ...

Back in October 2024, 16-year-old Darion Davis was originally hospitalized for an suspected asthma attack and later died in ...

Depemokimab-ulaa (Exdensur) has been approved by the US FDA as add-on maintenance therapy for severe asthma with an ...

The FDA has approved GSK’s Exdensur (depemokimab-ulaa) as an add-on maintenance therapy for adolescents and adults with severe asthma characterized by an eosinophilic phenotype. 1 ...

The FDA has approved Exdensur depemokimab-ulaa as an add-on maintenance therapy for severe asthma in patients aged 12 and older, supported by Phase III SWIFT trial data showing significant reductions ...

India’s air quality challenge is no longer a seasonal concern. It is a persistent public health issue that touches families, cities and insurers alike. As claims linked to respiratory and cardiac ...

US FDA approves GSK’s Exdensur for the treatment of severe asthma: London, UK Thursday, December 18, 2025, 11:00 Hrs [IST] GSK plc announced that the US Food and Drug Administra ...